Trial · NCT02409667
Results by group96
Each measurement the trial posted, group by group, in the words and numbers it posted.
1 to 20 of 96
Download this page as JSON| Outcome | Group | Category | Value | Spread | Units |
|---|---|---|---|---|---|
| Maintenance of PASI 90 Response at Week 52 in Participants With a PASI 90 Response at Week 24 | Treatment Period 2: Group 1 | 552 | Participants | ||
| Maintenance of PASI 90 Response at Week 52 in Participants With a PASI 90 Response at Week 24 | Treatment Period 2: Group 2 | 496 | Participants | ||
| Key Secondary: PASI 90 Response Rate at Week 52 in Participants With a PASI Response of ≥75 to <90 at Week 24 | Treatment Period 2: Group 3 | 53 | Participants | ||
| Key Secondary: PASI 90 Response Rate at Week 52 in Participants With a PASI Response of ≥75 to <90 at Week 24 | Treatment Period 2: Group 4 | 52 | Participants | ||
| PASI 50, PASI 75, PASI 100 and IGA Mod 2011 0 or 1 Responders at Week 52 in Participants With a PASI 90 Response at Week 24 | Treatment Period 2: Group 1 | PASI 50 | 608 | Participants | |
| PASI 50, PASI 75, PASI 100 and IGA Mod 2011 0 or 1 Responders at Week 52 in Participants With a PASI 90 Response at Week 24 | Treatment Period 2: Group 2 | PASI 50 | 624 | Participants | |
| PASI 50, PASI 75, PASI 100 and IGA Mod 2011 0 or 1 Responders at Week 52 in Participants With a PASI 90 Response at Week 24 | Treatment Period 2: Group 1 | PASI 75 | 597 | Participants | |
| PASI 50, PASI 75, PASI 100 and IGA Mod 2011 0 or 1 Responders at Week 52 in Participants With a PASI 90 Response at Week 24 | Treatment Period 2: Group 2 | PASI 75 | 588 | Participants | |
| PASI 50, PASI 75, PASI 100 and IGA Mod 2011 0 or 1 Responders at Week 52 in Participants With a PASI 90 Response at Week 24 | Treatment Period 2: Group 1 | PASI 90 | 553 | Participants | |
| PASI 50, PASI 75, PASI 100 and IGA Mod 2011 0 or 1 Responders at Week 52 in Participants With a PASI 90 Response at Week 24 | Treatment Period 2: Group 2 | PASI 90 | 496 | Participants | |
| PASI 50, PASI 75, PASI 100 and IGA Mod 2011 0 or 1 Responders at Week 52 in Participants With a PASI 90 Response at Week 24 | Treatment Period 2: Group 1 | PASI 100 | 378 | Participants | |
| PASI 50, PASI 75, PASI 100 and IGA Mod 2011 0 or 1 Responders at Week 52 in Participants With a PASI 90 Response at Week 24 | Treatment Period 2: Group 2 | PASI 100 | 305 | Participants | |
| PASI 50, PASI 75, PASI 100 and IGA Mod 2011 0 or 1 Responders at Week 52 in Participants With a PASI 90 Response at Week 24 | Treatment Period 2: Group 1 | IGA mod 2011 | 564 | Participants | |
| PASI 50, PASI 75, PASI 100 and IGA Mod 2011 0 or 1 Responders at Week 52 in Participants With a PASI 90 Response at Week 24 | Treatment Period 2: Group 2 | IGA mod 2011 | 529 | Participants | |
| PASI 50, PASI 75, PASI 100 and IGA Mod 2011 0 or 1 Responders at Week 52 in Participants With a PASI Response of ≥75 to <90 at Week 24 | Treatment Period 2: Group 3 | PASI 50 | 98 | Participants | |
| PASI 50, PASI 75, PASI 100 and IGA Mod 2011 0 or 1 Responders at Week 52 in Participants With a PASI Response of ≥75 to <90 at Week 24 | Treatment Period 2: Group 4 | PASI 50 | 88 | Participants | |
| PASI 50, PASI 75, PASI 100 and IGA Mod 2011 0 or 1 Responders at Week 52 in Participants With a PASI Response of ≥75 to <90 at Week 24 | Treatment Period 2: Group 3 | PASI 75 | 74 | Participants | |
| PASI 50, PASI 75, PASI 100 and IGA Mod 2011 0 or 1 Responders at Week 52 in Participants With a PASI Response of ≥75 to <90 at Week 24 | Treatment Period 2: Group 4 | PASI 75 | 80 | Participants | |
| PASI 50, PASI 75, PASI 100 and IGA Mod 2011 0 or 1 Responders at Week 52 in Participants With a PASI Response of ≥75 to <90 at Week 24 | Treatment Period 2: Group 3 | PASI 90 | 53 | Participants | |
| PASI 50, PASI 75, PASI 100 and IGA Mod 2011 0 or 1 Responders at Week 52 in Participants With a PASI Response of ≥75 to <90 at Week 24 | Treatment Period 2: Group 4 | PASI 90 | 52 | Participants |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT02409667/results